WHO WE ARE

We are a privately held medical device company developing a novel, rapid-acting brain stimulation technology designed to treat people suffering from major depressive disorder (MDD) who have not responded to existing treatments.

OUR MISSION

RESTORING MENTAL HEALTH.

Depression is caused by identifiable changes in brain networks.

We can restore healthy neural activity and relieve symptoms of depression.

WHAT WE DO

Breakthrough technology. Advanced imaging, individualized targeting, and novel stimulation patterns yield a new approach to personalized neurostimulation for people with treatment-resistant depression.

Leadership

Brett Wingeier
Brett Wingeier
PhD
Co-Founder and Chief Executive Officer

Previously CEO and co-founder of Halo Neuroscience. 20 years of neuromodulation industry experience. NeuroPace and ATI alumnus, former principal engineer and clinical scientist. Registered patent agent and prolific inventor with 60+ US patents.

Brandon Bentzley
Brandon Bentzley
MD, PhD
Co-Founder and Chief Scientific Officer

Lead developer of SAINT and previously Director of Innovation at Stanford Brain Stimulation Lab. Brandon is a Psychiatrist, technologist, and neuroscientist with record of NASA and NIH-funded research in basic and clinical domains.

 

Scott Ashworth
Scott Ashworth

Chief Commercial Officer

30+ years leadership in the medical device and health care industries, both Fortune 500 and startups.  Previously CCO of DocSpera; deep sales and marketing experience at Hearst Health, Gauss, HeartFlow, and Siemens.

 

Romain Moreau-Gobard
Romain Moreau-Gobard
Vice President of
Software Engineering

20 years’ experience in advanced medical imaging software, previously VP of software engineering for Advanced Scanners.  Technical leader at HeartFlow and Siemens, and holder of 15+ US and international patents.

Erica Lundmark
Erica Lundmark
Vice President of
Hardware Engineering

20+ years’ engineering experience in the medical device industry with focus on hardware, systems, electrical, wireless communications, and medical standards compliance; one of the very few people who has designed embedded systems currently running in thousands of human heads. InCube Labs, Sacramed, NeuroPace, and St Jude Medical / Ventritex alumnus.

Tammy Morton
Tammy Morton
Vice President of
Clinical Affairs

25 years’ experience in planning and executing clinical trials to support approval of class II and class III medical devices in a variety of therapeutic areas at both startups and large companies. Previously VP of clinical affairs at Radial Medical and Halo Neuroscience; in-depth clinical affairs experience at Gynesonics, Abbott Vascular and Bailer Research.

Tim_Hale
Timothy Hale
Vice President of Marketing
20+ years of medical device and pharmaceutical experience launching and commercializing disruptive technologies and indications. Previously Senior Director of Global Marketing at AngioDynamics and Neuronetics. Deep experience in lifecycle marketing, including product development and multiple product launches.

Investors

Heath Lukatch
Heath Lukatch
PhD
Founder and Managing Partner – Red Tree Venture Capital

Previously Partner, Managing Director, and Life Sciences Investment Team Leader in TPG’s Biotech, Growth and RISE platforms; co-founder and Partner at Novo Ventures’ San Francisco office; Managing Director at Piper Jaffray Ventures; co-founder and CEO of AutoMate Scientific. Led multiple investments with successful exits, including Amira, AnaptysBio, Cianna Medical, Engage Therapeutics, Elevation Pharma, Flexion, FoldRx, Spinifex and Vaxcyte. Currently chairman of publicly traded companies Inogen and Satsuma Pharmaceuticals. McKinsey alumnus with PhD in neuroscience from Stanford.

Andrew Firlik
Andrew Firlik
MD
Co-Founder and Managing Partner –
JAZZ Venture Partners

Deep experience in venture capital investment, company building, technology development, and neurosurgery. Previous partner at Flare Capital Partners and principal at Canaan Partners; founder and key inventor of Northstar Neuroscience (IPO in 2006, subsequently acquired by St. Jude Medical); was chairman of IntElect Medical (acquired by Boston Scientific). Led investments with successful exit and held board seats at BridgePoint Medical, Explorys, Eyefluence, Visiogen, and more. Board-certified neurosurgeon with over 50 medical articles and numerous patents.